Thursday, May 20, 2021 11:01:56 AM
Mymetics Corporation Overview May 2021
2009 2012 Phase I study Leroux Roels , Belgium (n=24) Publication: PlosOne , Feb.
https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0055438
Kinesis Pharma B.V. acquired by Venn Life Sciences
Lage Mosten 29
4822 NK Breda
Netherlands
https://www.crunchbase.com/acquisition/venn-life-sciences-acquires-kinesis-pharma-b-v--df3bd778
Dalkey, Dublin, Ireland
https://www.vennlifesciences.com/
Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine
Peptide-loaded virosomes were obtained by adding 125 µg/mL M158–66 peptide (GILGFVFTL, kindly provided by the Netherlands Cancer Institute) to the virosomes (1:36 peptide:protein w/w ratio) prior to detergent removal to enable peptide encapsulation.
https://link.springer.com/article/10.1007/s11095-014-1556-3
produced by H. Hilkmann, Netherlands Cancer Institute,
Amsterdam, The Netherlands)
https://pure.rug.nl/ws/portalfiles/portal/2969052/c5.pdf
epitope RAHYNIVTF produced in the labora-tory of Ton Schumacher (Netherlands Cancer Institute,Amsterdam, the Netherlands)
https://www.researchgate.net/publication/6494537_A_virosomal_immunization_strategy_against_cervical_cancer_and_pre-malignant_cervical_disease
Cancer researchers’ finding sheds light on COVID immunity
https://www.nki.nl/news-events/news/cancer-researchers-finding-sheds-light-on-covid-immunity/
Is RK & gang working w/ Netherlands Cancer Institute ?
2009 2012 Phase I study Leroux Roels , Belgium (n=24) Publication: PlosOne , Feb.
https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0055438
Kinesis Pharma B.V. acquired by Venn Life Sciences
Lage Mosten 29
4822 NK Breda
Netherlands
https://www.crunchbase.com/acquisition/venn-life-sciences-acquires-kinesis-pharma-b-v--df3bd778
Dalkey, Dublin, Ireland
https://www.vennlifesciences.com/
Influenza T-cell Epitope-Loaded Virosomes Adjuvanted with CpG as a Potential Influenza Vaccine
Peptide-loaded virosomes were obtained by adding 125 µg/mL M158–66 peptide (GILGFVFTL, kindly provided by the Netherlands Cancer Institute) to the virosomes (1:36 peptide:protein w/w ratio) prior to detergent removal to enable peptide encapsulation.
https://link.springer.com/article/10.1007/s11095-014-1556-3
produced by H. Hilkmann, Netherlands Cancer Institute,
Amsterdam, The Netherlands)
https://pure.rug.nl/ws/portalfiles/portal/2969052/c5.pdf
epitope RAHYNIVTF produced in the labora-tory of Ton Schumacher (Netherlands Cancer Institute,Amsterdam, the Netherlands)
https://www.researchgate.net/publication/6494537_A_virosomal_immunization_strategy_against_cervical_cancer_and_pre-malignant_cervical_disease
Cancer researchers’ finding sheds light on COVID immunity
https://www.nki.nl/news-events/news/cancer-researchers-finding-sheds-light-on-covid-immunity/
Is RK & gang working w/ Netherlands Cancer Institute ?
